Emergent BioSolutions board member Sullivan retires after 19 years

Emergent BioSolutions Inc. (NYSE: EBS) announced that Dr. Louis W. Sullivan will retire from the company's board of directors effective November 14 after 19 years of service.

Sullivan joined Emergent's board in 2006 and most recently served as chair of the compensation committee and a member of the nominating and corporate governance committee. He previously served as president of Morehouse School of Medicine from 1981 to 1989 and from 1993 to 2002, and as Secretary of the Department of Health and Human Services from 1989 to 1993.

"For nearly two decades, Dr. Sullivan has been a trusted advisor and champion of Emergent's mission to protect and save lives," said Joe Papa, president and CEO of Emergent. "On behalf of the Board and the entire Emergent team, I want to thank him for his distinguished leadership and contributions."

The Gaithersburg, Maryland-based biotechnology company develops protective and life-saving solutions for health threats including smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. The announcement was made in a company press release.

You May Also Be Interested In

• Trump: Will Be Making A Speech To The Nation On Thursday 9pm
• Cytokinetics (CYTK) July 100 and January 80 calls active, share price down 3.9%
• Humana (HUM) call put ratio 1.5 calls to 1 put as share price up 3.7%